Buys
Open market- Shares
- Avg price
- Total value
Jakob Dupont - Director at Pyxis Oncology, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- PYXS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Jakob Dupont in Pyxis Oncology, Inc.
Sells
Open market- Shares
- -35,000
- Avg price
- $3.06
- Total value
- -$107,100
Net
Past year- Shares
- -35,000
- Share %
- -100%
- Total value
- -$107,100
Reported holdings for Jakob Dupont in Pyxis Oncology, Inc.
Form 4 holding
Director
Pyxis Oncology, Inc.
- Security class
- Common Stock
- Shares / value
- 38,741
- Estimated value
- $118,547
- Report date
- 30 Jun 2026
- Price
- $3.06
- Ownership
- Direct
Form 4 holding
Director
Pyxis Oncology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 46,000
- Estimated value
- $36,239
- Report date
- 20 Aug 2026
- Price
- $0.9800
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jakob Dupont in Pyxis Oncology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.